Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

ClinicalTrials.gov ID: NCT00852202

Public ClinicalTrials.gov record NCT00852202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled Study of RGH-188 (Cariprazine) in Bipolar Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.

Study identification

NCT ID
NCT00852202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
234 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009 (Actual)
Primary completion
Jun 15, 2010 (Actual)
Completion
Jun 15, 2010 (Actual)
Last update posted
Aug 23, 2018

2009 – 2010

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Forest Investigative Site 005 Encino California 91316 —
Forest Investigative Site 017 Garden Grove California 92845 —
Forest Investigative Site 027 National City California 91950 —
Forest Investigative Site 013 Newport Beach California 92660 —
Forest Investigative Site 010 Oceanside California 92056 —
Forest Investigative Site 020 Bradenton Florida 34208 —
Forest Investigative Site 007 Jacksonville Florida 32216 —
Forest Investigative Site 019 Kissimmee Florida 34741 —
Forest Investigative Site 026 Orlando Florida 32806 —
Forest Investigative Site 012 West Palm Beach Florida 33407 —
Forest Investigative Site 024 Glen Burnie Maryland 21061 —
Forest Investigative Site 029 Creve Coeur Missouri 63141 —
Forest Investigative Site 002 Omaha Nebraska 68131 —
Forest Investigative Site 028 Cherry Hill New Jersey 08002 —
Forest Investigative Site 001 The Bronx New York 10467 —
Forest Investigative Site 018 Durham North Carolina 27710 —
Forest Investigative Site 004 Dayton Ohio 45417 —
Forest Investigative Site 022 Mason Ohio 45040 —
Forest Investigative Site 015 Portland Oregon 97210 —
Forest Investigative Site 006 Media Pennsylvania 19063 —
Forest Investigative Site 011 Philadelphia Pennsylvania 19107 —
Forest Investigative Site 014 Nashville Tennessee 37212 —
Forest Investigative Site 023 Irving Texas 75062 —
Forest Investigative Site 003 Woodstock Vermont 05091 —
Forest Investigative Site 009 Bellevue Washington 98004 —
Forest Investigative Site 016 Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00852202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00852202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →